Meta-analysis of the efficacy of the pretreatment neutrophil-to-lymphocyte ratio as a predictor of prognosis in renal carcinoma patients receiving tyrosine kinase inhibitors.

Meta-analysis of the efficacy of the pretreatment neutrophil-to-lymphocyte ratio as a predictor of prognosis in renal carcinoma patients receiving tyrosine kinase inhibitors.

Item
http://www.wikidata.org/entity/Q37536769
Association of neutrophil-lymphocyte ratio and T lymphocytes with the pathogenesis and progression of HBV-associated primary liver cancer.Preoperative neutrophil-lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle-invasive bladder cancerPrognostic significance of neutrophil-to-lymphocyte ratio in cervical cancer: A systematic review and meta-analysis of observational studies.Prognostic role of neutrophil-lymphocyte ratio in nasopharyngeal carcinoma: A meta-analysis.Prognostic significance of neutrophil to lymphocyte ratio in ovarian cancer: evidence from 4,910 patients.Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients: A meta-analysis.Prognostic role of the neutrophil-to-lymphocyte ratio (NLR) in patients with operable ampullary carcinoma.Prognostic value of systemic inflammatory markers in ovarian Cancer: a PRISMA-compliant meta-analysis and systematic review.
P2860

Meta-analysis of the efficacy of the pretreatment neutrophil-to-lymphocyte ratio as a predictor of prognosis in renal carcinoma patients receiving tyrosine kinase inhibitors.

Item
http://www.wikidata.org/entity/Q37536769
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Meta-analysis of the efficacy ...... ng tyrosine kinase inhibitors.
@en
Meta-analysis of the efficacy ...... ng tyrosine kinase inhibitors.
@nl
type
label
Meta-analysis of the efficacy ...... ng tyrosine kinase inhibitors.
@en
Meta-analysis of the efficacy ...... ng tyrosine kinase inhibitors.
@nl
prefLabel
Meta-analysis of the efficacy ...... ng tyrosine kinase inhibitors.
@en
Meta-analysis of the efficacy ...... ng tyrosine kinase inhibitors.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Meta-analysis of the efficacy ...... ng tyrosine kinase inhibitors.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932